{
    "name": "tagraxofusp",
    "comment": "Rx",
    "other_names": [
        "Elzonris",
        "tagraxofusp-erzs"
    ],
    "classes": [
        "Antineoplastics",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/elzonris-tagraxofusp-1000284",
    "pregnancy": {
        "common": [
            "Based on its mechanism of action, therapy has potential for adverse effects on embryo-fetal development",
            "Data are not available on use in pregnant women to inform a drug-associated risk of adverse developmental outcomes",
            "Advise pregnant women of potential risks to the fetus",
            "Conduct pregnancy testing in females of reproductive potential within 7 days before initiating treatment"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Advise females to use acceptable contraceptive methods during treatment and for at least 1 week after last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data are available on the presence of drug in human milk, the effects on the breastfed child, or the effects on milk production",
            "Because of potential for serious adverse reactions in breastfed children from tagraxofusp, breastfeeding is not recommended during treatment and for 1 week after last dose"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Capillary leak syndrome",
                    "description": [
                        "Capillary leak syndrome (CLS), which may be life-threatening or fatal, can occur in patients receiving tagraxofusp",
                        "Monitor for signs and symptoms of CLS and take actions as recommended",
                        "Before initiating therapy, ensure patient has adequate cardiac function and serum albumin â‰¥3.2 g/d",
                        "During treatment, monitor serum albumin levels prior to initiation of each dose and as indicated clinically thereafter, and assess patients for other signs or symptoms of CLS, including weight gain and new-onset or worsening edema (eg, pulmonary edema, hypotension, hemodynamic instability)"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Capillary leak syndrome reported; interrupt dose and manage according to presenting symptoms",
                "May cause severe hypersensitivity reactions (eg, rash, pruritus, stomatitis, wheezing); monitor for hypersensitivity reactions during treatment; interrupt infusion and provide supportive care as needed if a hypersensitivity reaction occurs",
                "Treatment was associated with elevations in liver enzymes; monitor AST/ALT prior to each infusion; elevation of liver enzymes reversible following dose interruption"
            ],
            "specific": []
        }
    },
    "interactions": [
        {
            "classification_type": "Monitor Closely",
            "interaction_with": "siponimod",
            "description": {
                "common": "siponimod and tagraxofusp both increase  immunosuppressive effects; risk of infection. Use Caution/Monitor. Caution if coadministered because of additive immunosuppressive effects during such therapy and in the weeks following administration. When switching from drugs with prolonged immune effects, consider the half-life and mode of action of these drugs to avoid unintended additive immunosuppressive effects."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Glucose increased",
            "percent": "87"
        },
        {
            "name": "ALT increased",
            "percent": "82"
        },
        {
            "name": "AST increased",
            "percent": "79"
        },
        {
            "name": "Albumin decreased",
            "percent": "77"
        },
        {
            "name": "Platelets decreased",
            "percent": "67"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "60"
        },
        {
            "name": "Calcium decreased",
            "percent": "57"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "55"
        },
        {
            "name": "Sodium decreased",
            "percent": "50"
        },
        {
            "name": "Nausea",
            "percent": "49"
        },
        {
            "name": "Fatigue",
            "percent": "45"
        },
        {
            "name": "Peripheral edema",
            "percent": "43"
        },
        {
            "name": "Pyrexia",
            "percent": "43"
        },
        {
            "name": "Neutrophils decreased",
            "percent": "37"
        },
        {
            "name": "Weight increased",
            "percent": "31"
        },
        {
            "name": "Phosphate decreased",
            "percent": "30"
        },
        {
            "name": "Chills",
            "percent": "29"
        },
        {
            "name": "Headache",
            "percent": "29"
        },
        {
            "name": "Hypotension",
            "percent": "29"
        },
        {
            "name": "Creatinine increased",
            "percent": "27"
        },
        {
            "name": "Alkaline phosphatase increased",
            "percent": "26"
        },
        {
            "name": "Decreased appetite",
            "percent": "24"
        },
        {
            "name": "Constipation",
            "percent": "23"
        },
        {
            "name": "Potassium increased",
            "percent": "21"
        },
        {
            "name": "Vomiting",
            "percent": "21"
        },
        {
            "name": "Diarrhea",
            "percent": "20"
        },
        {
            "name": "Magnesium decreased",
            "percent": "20"
        },
        {
            "name": "Dizziness",
            "percent": "20"
        },
        {
            "name": "Febrile neutropenia",
            "percent": "20"
        },
        {
            "name": "Back pain",
            "percent": "20"
        },
        {
            "name": "Dyspnea",
            "percent": "19"
        },
        {
            "name": "Tachycardia",
            "percent": "17"
        },
        {
            "name": "Insomnia",
            "percent": "17"
        },
        {
            "name": "Anxiety",
            "percent": "15"
        },
        {
            "name": "Hypertension",
            "percent": "15"
        },
        {
            "name": "Cough",
            "percent": "14"
        },
        {
            "name": "Magnesium increased",
            "percent": "14"
        },
        {
            "name": "Bilirubin increased",
            "percent": "14"
        },
        {
            "name": "Epistaxis",
            "percent": "14"
        },
        {
            "name": "Oropharyngeal pain",
            "percent": "12"
        },
        {
            "name": "Anxiety",
            "percent": "15"
        },
        {
            "name": "Confusional state",
            "percent": "11"
        },
        {
            "name": "Glucose decreased",
            "percent": "11"
        },
        {
            "name": "Platelets decreased",
            "percent": "53"
        },
        {
            "name": "AST increased",
            "percent": "37"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "35"
        },
        {
            "name": "Neutrophils decreased",
            "percent": "31"
        },
        {
            "name": "ALT increase",
            "percent": "30"
        },
        {
            "name": "Glucose increased",
            "percent": "20"
        },
        {
            "name": "Febrile neutropenia",
            "percent": "18"
        },
        {
            "name": "Phosphate decreased",
            "percent": "11"
        },
        {
            "name": "Petechiae",
            "percent": "10"
        },
        {
            "name": "Pruritus",
            "percent": "10"
        },
        {
            "name": "Hematuria",
            "percent": "10"
        },
        {
            "name": "Sodium increased",
            "percent": "10"
        },
        {
            "name": "Pain in extremity",
            "percent": "10"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "9"
        },
        {
            "name": "Hypotension",
            "percent": "9"
        },
        {
            "name": "Fatigue",
            "percent": "7"
        },
        {
            "name": "Hypertension",
            "percent": "6"
        },
        {
            "name": "Magnesium increased",
            "percent": "3"
        },
        {
            "name": "Potassium increased",
            "percent": "2"
        },
        {
            "name": "Back pain",
            "percent": "2"
        },
        {
            "name": "Pain in extremity",
            "percent": "2"
        },
        {
            "name": "Dyspnea",
            "percent": "2"
        },
        {
            "name": "Calcium decreased",
            "percent": "2"
        },
        {
            "name": "Peripheral edema",
            "percent": "1"
        },
        {
            "name": "Chills",
            "percent": "1"
        },
        {
            "name": "Epistaxis",
            "percent": "1"
        },
        {
            "name": "Alkaline phosphatase increased",
            "percent": "1"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": null
        }
    ]
}